Please login to the form below

Not currently logged in
Email:
Password:

Laura Atkinson promoted to compliance manager at Insight Research

Fills newly created role to ensure market research agency follows best practice in legal and ethical guidelines

Laura Atkinson - Insight ResearchLaura Atkinson has been promoted to newly created role of compliance manager at Insight Research Group.

Atkinson has been at pharma marketing research agency since 2003, joining as senior language executive.

In her new role, she will ensure that Insight adheres to best practice regarding compliance in the industry, as well as making sure Insight follows legal and ethical industry and trade association guidelines, such as the Market Research Society Code of Conduct and issues specified by the Assoication of the British Pharmaceutical Indsutry (ABPI).

This is the first time Insight has had a dedicated compliance manager to handle such issues.

Jane Shirley, joint managing director at Insight said: “Insight takes ethics, good governance, guideline compliance and best research practice very seriously as a research agency.  We recognise the importance our clients place on their suppliers working to the highest standards of governance and feel we are at the forefront of the industry in creating a new role to ensure this is delivered.”

23rd April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics